From The Wall Street Journal, overnight, then:
. . . .Mr. Hassan brought Mr. MacMillan to Pharmacia in 2000 to oversee consumer products and four smaller divisions. He says he soon alerted fellow directors that the executive "could be a potential CEO."
Ahead of board presentations, he coached Mr. MacMillan to keep things simple, leave time for frank discussion and "show your humility," Mr. Hassan remembers. "Really value what (directors) say," he told his protégé. "It can't be fake."
Pharmacia board member William U. Parfet was so impressed that in 2003, he recruited Mr. MacMillan to be president of Stryker Corp., where Mr. Parfet also was a director. Promoted to CEO of the medical-device maker at age 41 in January 2005, Mr. MacMillan won analysts' accolades for its steady performance as the orthopedics market stalled.
Yet Stryker forced out Mr. MacMillan early last year, partly because some directors were bothered by his relationship with an ex-flight attendant for its corporate jets while his wife pursued a divorce, people familiar with the situation have said. In hindsight, Mr. MacMillan realizes he joined Stryker when he had just begun to grasp the nuances of board management from Mr. Hassan.
"Managing a board was not my strength at Stryker," Mr. MacMillan concedes. "It hurt me." He now leads sBioMed LLC, a private manufacturer of infection-control products. . . .
R-e-e-e-e-e-ally?! You think so? Nah. . . I don't. Priceless.
1 comment:
The gift of self-awareness often arrives too late for most and never for others. Only time will tell which of these two groups Mr. MacMillan belongs to.
In a flash of ho-hum Vioxx news: http://www.medpagetoday.com/PracticeManagement/Medicolegal/41603
Post a Comment